Nisa Investment Advisors’s CorMedix CRMD Stock Holding History

Nisa Investment Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.3K	Buy	1,057 +221	+26%	+$1.75K	﹤0.01%	2514
2026 Q1	$5.68K	Buy	836 +37	+5%	+$273	﹤0.01%	2425
2025 Q4	$9.29K	Hold	799	–	–	﹤0.01%	2257
2025 Q3	$9.29K	Hold	799	–	–	﹤0.01%	2306
2025 Q2	$9.84K	Buy	799 +676	+550%	+$7.46K	﹤0.01%	2274
2025 Q1	$758	Hold	123	–	–	﹤0.01%	2706
2024 Q4	$996	Hold	123	–	–	﹤0.01%	2684
2024 Q3	$994	Hold	123	–	–	﹤0.01%	2580
2024 Q2	$533	Buy	+123	New	+$625	﹤0.01%	2670
2022 Q1	–	Sell	-7,414	Closed	-$31K	–	2361
2021 Q4	$31K	Buy	+7,414	New	+$36.8K	﹤0.01%	1839

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nisa Investment Advisors's CRMD Position: Q2 2026 in Review

Nisa Investment Advisors increased its CorMedix (CRMD) stake by 26% in Q2 2026, buying an estimated $1.75K and bringing the position to 1,057 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2514.

Nisa Investment Advisors first reported a position in CRMD in Q4 2021 and has held it in 10 quarters since. The position peaked at $31K in Q4 2021. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Nisa Investment Advisors held 1,057 shares of CorMedix worth $8.3K as of Q2 2026.
Nisa Investment Advisors bought 221 CorMedix shares in Q2 2026, an estimated $1.75K.
CorMedix made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2514 holding.
Nisa Investment Advisors first reported a position in CorMedix in Q4 2021 and has held it in 10 quarters since.
Nisa Investment Advisors's CorMedix position peaked at $31K in Q4 2021.
193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.